TB-500
Payment Options
TB-500 5 mg - Hilma Biocare
The peptide comes as a powder with 5 mg stated per vial. Its exact amino acid sequence requires confirmation because the TB-500 name is used for different peptide presentations.
Manufacturer
Peptide
TB-500
Class
Peptide
Presentation
Powder for injectable preparation
Vial content
5 mg, equivalent to 5 000 mcg
Packaging
1 vial
How It Works
The product name refers to preparations related to thymosin beta 4, including a synthetic peptide from its actin binding region. Actin regulation affects how cells move and organise during tissue repair. The supplied specifications do not identify the peptide sequence, so the exact molecular identity cannot be confirmed from this file.
Cell Migration and Tissue Repair Research
Thymosin beta 4 research has demonstrated cell migration and blood vessel related repair activity in experimental systems. This explains interest in recovery from tendon and muscle injuries. Those findings do not establish the same effect for an unspecified TB-500 preparation or demonstrate faster recovery in healthy athletes.
- Investigating cell movement involved in repair.
- Studying pathways linked to actin organisation.
- Exploring tissue repair findings from thymosin related research.
Post Cycle Therapy
The peptide has no established role in androgen suppression and no established indication for steroid PCT. Limited human data and uncertain product identity prevent a complete description of its systemic endocrine effects.
Side Effects
Human safety data for marketed TB-500 preparations are inadequate to establish reliable adverse effect rates. Injection reactions, hypersensitivity and contamination are possible concerns. Research involving full length thymosin beta 4 does not establish the safety of a different fragment or an unverified preparation.










